Khiron Life Sciences Enters Mexican Cannabis Market With The Launch of Its First Nutraceutical Product Line
TORONTO, Dec. 3, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today that its wholly-owned subsidiary, Kuida Life Mexico S.A., has ... [Read]
Khiron Life Sciences Enters Peruvian Cannabis Market With Approval For Commercialization Of Kuida® CBD Cosmeceutical Brand
Syndicated under license via QuoteMedia Entry into Peru expands access to US $110 Billion Latin American beautycare market TORONTO, Nov. 27, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its ... [Read]
Khiron Life Sciences Achieves Milestone With Additional Cultivation Quotas From The Colombian Technical Quotas Group
Syndicated under license via QuoteMedia Quotas represent progress towards cultivating strains for commercial purposes in Q1 of 2019 TORONTO, Nov. 19, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt: A2JMZC), an integrated ... [Read]
Khiron Life Sciences Announces Completion of Warrant Acceleration
Syndicated under license via QuoteMedia TORONTO, Nov. 15, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, is pleased to announce that ... [Read]